Brief: Arix Bioscience Says CEO Joe Anderson Will Transition To Chief Investment Officer

Arix Bioscience

04/09/2018 07:57

Sept 4 (Reuters) - Arix Bioscience PLC  ARIX.L :
    * JOE ANDERSON, WHO HAS SERVED CHIEF EXECUTIVE OFFICER OF
ARIX
SINCE INCEPTION IN 2016, WILL TRANSITION TO CHIEF INVESTMENT
OFFICER
    * JOE WILL CONTINUE TO CHAIR INVESTMENT COMMITTEE AND AS OF
TODAY,
WILL STEP DOWN FROM BOARD OF ARIX
    * EXECUTIVE CHAIRMAN OF ARIX, JONATHAN PEACOCK, WILL ASSUME
CORPORATE AND OPERATING RESPONSIBILITIES

Source text for Eikon:  ID:nPRr4A3D3a 
Further company coverage:  ARIX.L 

 ((Reuters.Briefs@thomsonreuters.com;))